City

Columbus (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Ohio State University Comprehensive Cancer Center (1)

Collaborator

Clovis Oncology, Inc. (1)

ImmunoGen, Inc. (1)

Intervention

laboratory biomarker analysis (1)

mirvetuximab soravtansine (1)

pharmacokinetic study (1)

rucaparib camsylate (1)

Study Documents

Intervention Type

biological (1)

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

recurrent uterine carcinosarcoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting

BRCA1 Gene Mutation
+9 more

Laboratory Biomarker Analysis
+3 more

Columbus, Ohio

Ohio State University Comprehensive Cancer Center

Sep 16, 2022